Clinical Trial Update: Electrophysiologic Measures of Treatment Response in Alzheimer Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating electrophysiologic measures as a treatment-response biomarker in Alzheimer's disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED